News

Bayer CropScience Limited will hold a board meeting on November 3, 2026, to consider the unaudited financial results for the quarter ended September 30, 2026, and to consider the declaration of an interim dividend for the financial year 2026-27.

Bayer CropScience Limited, formerly known as Bayer CropScience Ltd, confirmed that details of dematerialized and rematerialized securities from July 1, 2026, to September 30, 2026, have been submitted to stock exchanges as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, with MUFG Intime India Private Limited, the company’s Registrar and Share Transfer Agent, handling the submission.

Bayer CropScience Limited will close its trading window for designated persons from October 1, 2026, until the declaration of its quarterly financial results for the quarter ended September 30, 2026, and two days thereafter, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Net profit of Bayer CropScience rose 15.39% to Rs 321.60 crore in the quarter ended June 2026 as against Rs 278.70 crore during the previous quarter ended June 2025. Sales declined 4.16% to Rs 1835.00 crore in the quarter ended June 2026 as against Rs 1914.60 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales1835.001914.60 -4 OPM %20.0318.20 - PBDT452.20362.40 25 PBT402.10335.20 20 NP321.60278.70 15 Powered by Capital Market - Live News

Bayer CropScience will hold a meeting of the Board of Directors of the Company on 5 August 2026.